BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 19951901)

  • 1. Survival prediction of gastric cancer by a seven-microRNA signature.
    Li X; Zhang Y; Zhang Y; Ding J; Wu K; Fan D
    Gut; 2010 May; 59(5):579-85. PubMed ID: 19951901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
    Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
    Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
    Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
    Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.
    Chen Z; Saad R; Jia P; Peng D; Zhu S; Washington MK; Zhao Z; Xu Z; El-Rifai W
    Cancer; 2013 Jun; 119(11):1985-93. PubMed ID: 23456798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of microRNA Signature in Patients with Gastric Cancers.
    Liu HT; Wang YW; Xing AY; Shi DB; Zhang H; Guo XY; Xu J; Gao P
    Sci Rep; 2017 Feb; 7():42806. PubMed ID: 28202938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections.
    Marchini S; Cavalieri D; Fruscio R; Calura E; Garavaglia D; Fuso Nerini I; Mangioni C; Cattoretti G; Clivio L; Beltrame L; Katsaros D; Scarampi L; Menato G; Perego P; Chiorino G; Buda A; Romualdi C; D'Incalci M
    Lancet Oncol; 2011 Mar; 12(3):273-85. PubMed ID: 21345725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA signature associated with outcome of gastric cancer patients following chemotherapy.
    Kim CH; Kim HK; Rettig RL; Kim J; Lee ET; Aprelikova O; Choi IJ; Munroe DJ; Green JE
    BMC Med Genomics; 2011 Nov; 4():79. PubMed ID: 22112324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma microRNA-based signatures to predict 3-year postoperative recurrence risk for stage II and III gastric cancer.
    Liu X; Zhang X; Zhang Z; Chang J; Wang Z; Wu Z; Wang C; Sun Z; Ge X; Geng R; Tang W; Dai C; Lin Y; Lin F; Sun M; Jia W; Xue W; Ji J; Hu Y; Qin G; Li J
    Int J Cancer; 2017 Nov; 141(10):2093-2102. PubMed ID: 28722210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
    Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
    Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomewide Expression Profiling Identifies a Novel miRNA-based Signature for the Detection of Peritoneal Metastasis in Patients With Gastric Cancer.
    Shimura T; Toden S; Kandimalla R; Toiyama Y; Okugawa Y; Kanda M; Baba H; Kodera Y; Kusunoki M; Goel A
    Ann Surg; 2021 Nov; 274(5):e425-e434. PubMed ID: 31663973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
    Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
    Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
    Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.
    Yang Y; Qu A; Zhao R; Hua M; Zhang X; Dong Z; Zheng G; Pan H; Wang H; Yang X; Zhang Y
    Mol Oncol; 2018 Dec; 12(12):2072-2084. PubMed ID: 30242969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients.
    Ji D; Qiao M; Yao Y; Li M; Chen H; Dong Q; Jia J; Cui X; Li Z; Xia J; Gu J
    EBioMedicine; 2018 Sep; 35():189-197. PubMed ID: 30166271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients.
    Kleivi Sahlberg K; Bottai G; Naume B; Burwinkel B; Calin GA; Børresen-Dale AL; Santarpia L
    Clin Cancer Res; 2015 Mar; 21(5):1207-14. PubMed ID: 25547678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.
    Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A
    Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer.
    Qiu X; Zhu H; Liu S; Tao G; Jin J; Chu H; Wang M; Tong N; Gong W; Zhao Q; Qiang F; Zhang Z
    J Gastroenterol Hepatol; 2017 Apr; 32(4):819-827. PubMed ID: 27529338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.